ZA872677B - Pharmaceutical compositions for the treatment of intermittent claudication - Google Patents

Pharmaceutical compositions for the treatment of intermittent claudication

Info

Publication number
ZA872677B
ZA872677B ZA872677A ZA872677A ZA872677B ZA 872677 B ZA872677 B ZA 872677B ZA 872677 A ZA872677 A ZA 872677A ZA 872677 A ZA872677 A ZA 872677A ZA 872677 B ZA872677 B ZA 872677B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
treatment
intermittent claudication
compound
hydroxyethyl starch
Prior art date
Application number
ZA872677A
Other languages
English (en)
Inventor
Gobert Jean
Verloes Rene
Original Assignee
Ucb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10596143&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA872677(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb filed Critical Ucb
Publication of ZA872677B publication Critical patent/ZA872677B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA872677A 1986-04-14 1987-04-14 Pharmaceutical compositions for the treatment of intermittent claudication ZA872677B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868609033A GB8609033D0 (en) 1986-04-14 1986-04-14 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA872677B true ZA872677B (en) 1987-10-05

Family

ID=10596143

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA872677A ZA872677B (en) 1986-04-14 1987-04-14 Pharmaceutical compositions for the treatment of intermittent claudication

Country Status (10)

Country Link
EP (1) EP0243336B1 (el)
JP (1) JPS62267226A (el)
AT (1) ATE53494T1 (el)
AU (1) AU7147787A (el)
CA (1) CA1288347C (el)
DE (1) DE3763141D1 (el)
DK (1) DK189787A (el)
GB (1) GB8609033D0 (el)
GR (1) GR3000758T3 (el)
ZA (1) ZA872677B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002053153A1 (ja) * 2000-12-28 2004-04-30 第一製薬株式会社 神経因性疼痛治療及び予防薬
CN106943377A (zh) * 2016-06-15 2017-07-14 重庆润泽医药有限公司 一种左旋奥拉西坦颗粒及其制备方法
CN106943376B (zh) * 2016-06-15 2018-10-23 重庆润泽医药有限公司 一种左旋奥拉西坦颗粒及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5027884A (el) * 1973-07-12 1975-03-22
DE3030863A1 (de) * 1980-08-14 1982-03-11 Albrecht M. Prof. Dr.med. 6072 Dreieich Ehrly Verwendung von hydroxyaethylstaerke zur behandlung von durchblutungssstoerungen

Also Published As

Publication number Publication date
GR3000758T3 (en) 1991-10-10
AU7147787A (en) 1987-10-15
DK189787D0 (da) 1987-04-13
ATE53494T1 (de) 1990-06-15
EP0243336B1 (fr) 1990-06-13
EP0243336A1 (fr) 1987-10-28
DK189787A (da) 1987-10-15
JPS62267226A (ja) 1987-11-19
CA1288347C (en) 1991-09-03
GB8609033D0 (en) 1986-05-21
DE3763141D1 (de) 1990-07-19

Similar Documents

Publication Publication Date Title
PH31617A (en) Novel thienylcarboxylates of amino alcohols, theirquaternary products and use of these compounds.
GB2223026B (en) Compositions and process for the treatment of textiles
EP0251369A3 (en) Pharmaceutical compositions endowed with sequestering activity for the biliary acids, containing colestyramin as their active principle, and process for preparing them
HUT44135A (en) Herbicide compositions containing triazol-sulfonamide derivatives as active components and process for producing the active components
IL83760A (en) 3-pyrazoliomethyl-3- cephem-4-carboxylate derivatives, process for the preparation thereof, and pharmacetuical compositions containing the same
PT86362A (en) Process for the preparation of anxiolytic compositions containing n-(1-azabicyclo ]2,2.2."-oct-3-yl) benzamides and thiobenzamides
HUT47103A (en) Process for producing 1,4-benzoxazine derivatives and pharmaceutical compositions comprising the same
GB2225787B (en) Compositions and process for the treatment of textiles
HUT45694A (en) Herbicide and growth-controllong compositions containing 5-amino-1-phenyl-pyrazoles as active components and process for producing the active components
HUT44131A (en) Herbicide compositions containing pyrazolo-pyrimidine derivatives as active components and process for producing the active components
HUT44130A (en) Herbicide compositions containing thiazolo-triazol-sulfonamide derivatives as active components and process for producing the active components
HUT44134A (en) Herbicide compositions containing triazolo-sulfonamide derivatives as active components and process for producing the active components
HUT47793A (en) Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components
CS212687A3 (en) Process for preparing compounds with nootropic activity
ATE26213T1 (de) Aeusserlich anzuwendende arzneimittelzubereitung enthaltend adenosin zur behandlung von herpes.
HUT46688A (en) Fungicide compositions containing carbamoyl-imidazol derivatives as active components and process for producing the active components
GR3015052T3 (en) Antibiotic GE 2270 factors A1, A2, A3 and H.
ZA872677B (en) Pharmaceutical compositions for the treatment of intermittent claudication
HUT47792A (en) Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components
ZA872276B (en) Pharmaceutical compositions containing 5-phenyl-1,3-dioxoalkenyl compounds
HUT47314A (en) Process for regulating the compositions of stable, mixed populations of microorganisms
LV10289B (en) New pentapeptide and a process for the preparation thereof
PT83192B (en) Process for preparing unsaturated compounds useful in the treatment of cardiovascular phatological conditions containing 1,4-di-hydropiridine-3,5-dicarboxylic acid derivatives
IL67411A0 (en) Crystalline human leukocyte interferon,its production and pharmaceutical compositions containing it
IL84804A0 (en) Plant defoliant compositions containing thiadiazole urea derivative and azacylcloheptane derivative and process for the preparation thereof